1
Cemiplimab for Secondary Angiosarcomas
Condition(s):Secondary Angiosarcoma; Locally Advanced Sarcoma; MetastasisLast Updated:February 3, 2022Recruiting
Cemiplimab: 108 Clinical Trials, Page 1 of 11
Hide Studies Not Open or Pending
2
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma: Safety and Biomarker Analysis
Condition(s):Merkel Cell CarcinomaLast Updated:November 17, 2022Recruiting
3
Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC
Condition(s):Cutaneous Squamous Cell Carcinoma; Cutaneous Squamous Cell Carcinoma of the Head and NeckLast Updated:November 4, 2022Terminated
4
PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung
Condition(s):Non-small Cell Lung Cancer (NSCLC)Last Updated:February 1, 2023Not yet recruiting
5
Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition(s):Head and Neck Squamous Cell Carcinoma; HNSCC; Squamous Cell Carcinoma of the Larynx; Squamous Cell Carcinoma of the Oral Cavity; Squamous Cell Carcinoma of HypopharynxLast Updated:August 4, 2022Withdrawn
6
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
Condition(s):Cutaneous Squamous Cell Carcinoma; Advanced Cutaneous Squamous Cell Carcinoma; Metastatic Cutaneous Squamous Cell CarcinomaLast Updated:February 3, 2023Active, not recruiting
7
Intralesional Cemiplimab for Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma
Condition(s):Cutaneous Squamous Cell Carcinoma; Basal Cell CarcinomaLast Updated:January 5, 2023Recruiting
8
ASP8374 + Cemiplimab in Recurrent Glioma
Condition(s):Glioblastoma; Recurrent GlioblastomaLast Updated:January 17, 2023Active, not recruiting
9
Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer
Condition(s):Metastatic Pancreatic CancerLast Updated:August 15, 2022Recruiting
10
A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer
Condition(s):Recurrent Skin Squamous Cell Carcinoma; Resectable Skin Squamous Cell Carcinoma; Stage I Skin Cancer; Stage II Skin Cancer; Stage III Skin CancerLast Updated:November 15, 2022Recruiting